Treatment & Availability
What is the span of our executive oversight and how we operate?
R&D, business and marketing
IPR
Marketing authorization holder Manufacturer of API
Private company
In the industry since 2002 with a focus on oncolytic virotherapy
Rigvir Group: established in 2014
2018: implementation of the restructuring strategy to become a sustainable Biotechnological Company